[ Resources ]
Guides, protocols, and articles on research-grade peptides. Free PDF downloads cover starter knowledge, application categories, synthesis & QC, and 2026 research trends. New articles are published regularly. Research use only.
Interactive utilities for research dosing and recovery
Tool
Compute syringe units, concentration, and vial duration for BPC-157, Retatrutide, GHK-Cu, MOTS-c, CJC-1295/Ipamorelin, Semax. Free.
Tool
A short assessment that scores your recovery, finds your primary limiter, and maps it to a research protocol track. Free.
Download the research layer
Starter Guide
Essential knowledge for researchers beginning peptide investigation. Purity standards, handling protocols, safety systems, and a complete reference glossary.
Quick Reference
A researcher's field guide to peptide categories, mechanisms, and therapeutic research areas. Mechanism, application domain, and clinical evidence at a glance.
Technical Reference
Solid-phase peptide synthesis fundamentals, analytical techniques, quality control systems, and troubleshooting protocols for research-grade production.
Intelligence Brief
The state of peptide science: next-generation compounds, AI-accelerated discovery, oral delivery breakthroughs, and the regulatory landscape shaping research access.
Research notes, protocols, and city-specific guides
Compound Guide
Thymulin research overview: the zinc-dependent thymic peptide mechanism, autoimmune and aging studies, and where the human trial evidence still falls short.
Compound Guide
Tirzepatide research overview covering the dual GIP/GLP-1 receptor mechanism, SURPASS-3 and SURMOUNT-1 trial data showing up to 20.9% weight loss at 72 weeks, and the Mounjaro and Zepbound FDA approvals.
Compound Guide
Semaglutide research overview covering the GLP-1 receptor mechanism, SUSTAIN and STEP trial data showing 14.9% weight loss at 68 weeks, and the SELECT cardiovascular trial (n=17,604) that reduced major adverse cardiac events.
Compound Guide
How researchers isolated the lipolytic tail of growth hormone, the beta3-adrenergic mechanism, animal-study numbers from Ng and Heffernan, and newer osteoarthritis and pain research under the LAT8881 name.
Compound Guide
GHRP-2 research overview covering the GHS-R1a mechanism, pediatric and adult GH secretion trials, a 33-minute terminal half-life in children, appetite data, and pralmorelin's 2004 diagnostic approval in Japan.
Compound Guide
GHRP-6 was the first synthetic hexapeptide shown to release growth hormone, in 1984, 15 years before its receptor's natural ligand, ghrelin, was identified. Covers the human GHRH-dependence data (n=9), the obesity stimulation test, and the appetite effects it shares with ghrelin.
Compound Guide
DSIP is a 1977 Basel discovery with no identified receptor to this day. Covers the rat growth hormone data, conflicting human ACTH studies, and why controlled insomnia trials still disagree.
Compound Guide
Follistatin-344 is an AAV gene therapy construct that blocks myostatin signaling. Covers the 2008 mdx mouse study, the 2009 nonhuman primate trial, and the six-patient Becker muscular dystrophy trial (NCT01519349).
Compound Guide
Thymosin Alpha-1 signals through TLR2/4/9 on dendritic cells. Covers the 1977 Goldstein discovery, the 1998 hepatitis B trial (n=98, 40.6% response), and the split verdict on sepsis: ETASS 2013 (n=361) versus the negative 2025 TESTS trial (n=1,106).
Compound Guide
Kisspeptin signals through KISS1R (GPR54) to control GnRH release. Covers the 2003 Seminara and de Roux genetic discoveries, the KNDy pulse-generator model, sexual dimorphism in LH response, and the 2015 IVF trigger trial (n=60, 62% live birth rate).
Compound Guide
LL-37 is the only human cathelicidin antimicrobial peptide, cleaved from hCAP-18 by proteinase 3. Covers antimicrobial and angiogenesis mechanisms, psoriasis and rosacea immune signaling, and the 2014 venous leg ulcer trial (n=34).
Compound Guide
SS-31 (elamipretide) binds cardiolipin independent of membrane potential. Covers the 2004 Zhao mechanism paper, TAZPOWER and PROGRESS-HF trial data, and the September 2025 FDA approval of Forzinity for Barth syndrome.
Compound Guide
Humanin is a 24-aa peptide from the mtDNA 16S rRNA gene. Covers discovery (Hashimoto 2001, PNAS), Bax-binding and gp130 signaling mechanisms, NOD mouse beta cell data (n=12, 0.7 mg/kg), and Yen 2020 lifespan findings.
Compound Guide
MT-II is a cyclic alpha-MSH analogue developed at the University of Arizona. Covers MC1R/MC4R pharmacology, Wessells 1998 ED trial (n=10, 8/10 erections), tanning studies, side effects, and the PT-141 lineage.
Compound Guide
AOD-9604 is a synthetic C-terminal hGH fragment studied for lipolysis via beta-3 AR upregulation. Phase 2b OPTIONS trial (n=502) failed primary endpoint. GRAS status granted; not FDA approved for any indication.
Compound Guide
Sermorelin (GHRH 1-29 analogue) has an 11-12 minute plasma half-life. FDA approved as Geref in 1997. Mechanism, pediatric trial data (n=110), pharmacokinetics, and comparison to CJC-1295 and tesamorelin reviewed.
Compound Guide
Tesamorelin (Egrifta) is the only FDA-approved GHRH analogue. Phase 3 data in 816 HIV patients showed 15-18% visceral fat reduction at 26 weeks. Mechanism, trials, IGF-1 effects, and evidence scope reviewed.
Compound Guide
Hexarelin (EP-23905) research overview: human trial GH data, cortisol co-stimulation, desensitization profile, cardioprotection via CD36, and comparison to ipamorelin and GHRP-6.
Compound Guide
IGF-1 LR3 research overview: reduced IGFBP binding, PI3K/Akt/mTOR signaling, cell culture applications, and in vivo findings in guinea pig and pig models.
Compound Guide
PT-141 research overview: bremelanotide mechanism at MC3R/MC4R, RECONNECT Phase 3 trial data in 1,267 women, FDA Vyleesi approval, and adverse event profile.
Compound Guide
Epitalon (AEDG) research overview covering telomerase activation findings, 11-31% rodent lifespan data, neurogenic effects, and why human RCT evidence is still absent.
Compound Guide
Selank research overview covering enkephalinase inhibition, GABAergic modulation, BDNF effects, and the limits of the current animal-model evidence base.
Protocol
Cold chain peptide shipping across Indonesia's archipelago: packaging options, inter-island logistics, and arrival inspection for temperature-sensitive compounds.
Protocol
What causes peptide oxidation, which residues are most vulnerable, and practical prevention for research handling and tropical storage conditions.
Protocol
What drives peptide aggregation in reconstituted research solutions, how to detect it early, and practical prevention strategies covering pH, concentration, and storage.
Protocol
Bacteriostatic water mechanism, 28-day beyond-use date, per-draw needle hygiene, and contamination rates from peer-reviewed literature.
Protocol
How to prevent microbial contamination during peptide reconstitution: sterile field setup, stopper disinfection, hand hygiene sequence, and tropical climate adjustments. Literature-backed.
Protocol
How to calculate reconstitution concentration, convert mg to mcg, and determine the correct U-100 syringe draw volume for any research dose. Worked examples.
Protocol
How repeated freeze-thaw cycles degrade reconstituted peptides through aggregation and pH shifts, with stability data and aliquoting protocols.
Protocol
How amino acid composition determines solubility, with step-by-step guidance for aqueous, acidic, and DMSO-based reconstitution.
City Guide
BPOM Special Access Scheme, delivery to all 30 Kota Bandung districts, and storage guidance for the highland tropical climate.
City Guide
BPOM Special Access Scheme, next-day delivery across all DIY regencies, and storage guidance for Yogyakarta's tropical highland climate.
City Guide
BPOM Special Access Scheme, next-day delivery across East Java, and storage guidance for Surabaya's hot-humid tropical climate.
City Guide
BPOM Special Access Scheme requirements, same-day Jabodetabek delivery, and storage guidance for Indonesia's tropical climate.
City Guide
BPOM Special Access Scheme for research-use imports, cold-chain delivery to Canggu, Seminyak, Ubud, Sanur, and Uluwatu, and why Bali's Zone IVb climate demands freezer storage.
Comparison
BDNF neurotrophin pathways versus GABA-A modulation. Two indexed human studies for Semax, one for Selank. Mechanism table, evidence review, and protocol notes.
Comparison
The with-DAC form persists for 5.8-8.1 days via covalent albumin binding; modified GRF 1-29 clears in 30 minutes. Compare GH release patterns and what the human trial data shows.
Comparison
BPC-157 and TB-500 target tissue repair through distinct pathways. Compare mechanisms, evidence base, and research protocol use for these two peptides.
Comparison
Phase 2 retatrutide hit 24.2% weight loss at 48 weeks; Phase 3 tirzepatide 22.5% at 72 weeks. Why the datasets cannot be directly compared, what the GCGR component adds, and when TRIUMPH-5 head-to-head data arrives.
Comparison
Phase 2 retatrutide showed 24.2% weight loss at 48 weeks vs 14.9% for semaglutide in Phase 3. How the receptor mechanisms differ, what the trial designs mean for comparison, and where a head-to-head study stands.
Quality
The handling errors most consistently flagged in peer-reviewed protocols: reconstitution technique, container adsorption, freeze-thaw damage, math errors, and tropical storage.
Protocol
How site cycling prevents lipohypertrophy and maintains absorption consistency. Pharmacokinetic data from four PubMed-cited studies, standard abdomen-thigh-arm patterns, and needle guidance for research protocols.
Protocol
BAC water adds 0.9% benzyl alcohol to extend reconstituted peptide viability to 21 days. Sterile water is preservative-free and single-use. When each diluent applies.
Protocol
How route choice affects Cmax, Tmax, and duration. Leuprolide acetate Phase I data, BPC-157 bioavailability figures, needle gauge, insertion angle, and volume limits.
Compound Guide
Mechanism, wound healing data, cardiac studies, and where the thymosin beta-4 evidence actually ends. Six cited PubMed sources.
Compound Guide
ACTH 4-7 Pro-Gly-Pro mechanism, BDNF upregulation, rat ischemia model findings, two indexed Russian stroke trials, and the only fMRI study in healthy volunteers.
Compound Guide
DAC albumin-binding mechanism, 5.8-8.1 day half-life from the Teichman 2006 JCEM trial, ipamorelin selectivity versus GHRP-6, and where the human evidence stands.
Compound Guide
The 2015 Lee/Cohen founding study, nuclear translocation mechanism, AMPK-AICAR pathway, rodent efficacy data, exercise-induced release, and human plasma aging decline. What the peer-reviewed literature shows as of 2026.
Compound Guide
Collagen synthesis data (10-9 M peak), MMP-2 regulation, wound-healing rodent studies, skin penetration evidence, and the 2015-2018 gene expression analyses. What the peer-reviewed literature shows.
Compound Guide
Triple GLP-1/GIP/glucagon receptor agonist. Phase 2 NEJM data showing 24.2% weight loss at 48 weeks, TRIUMPH Phase 3 results, and comparison with semaglutide and tirzepatide.
Compound Guide
Three decades of rat-model data on GI protection, tendon repair, and angiogenesis. Covers the VEGFR2-Akt-eNOS pathway, FAK-paxillin signaling, and the current state of human trial evidence.
Quality
The purity figure on a COA is an HPLC peak-area ratio, not a mass assay. Covers what it measures, what MS confirms, TFA counter-ions, water content, and purity grade selection.
Protocol
Unit-to-mL conversion, reconstitution calculation, syringe size selection, and measurement accuracy evidence for small-volume subcutaneous peptide protocols.
Protocol
How ICH Zone IV conditions, residual moisture, and tropical humidity affect lyophilized peptide shelf life. Practical two-tier storage setup for Bali and Indonesia researchers.
Protocol
Step-by-step guide to reconstituting lyophilized research peptides. Covers BAC water selection, injection technique, concentration math, and refrigerated storage windows.